Shaping the Future of Oncology for Patients l Exelixis

Innovating medicine brings hope

CANCER IS OUR CAUSE

U.S. FDA approves new indication

Our flagship medicine is now available for certain patients with previously treated advanced neuroendocrine tumors.
Read Our Press Release

Our environmental, social and governance initiatives

Learn more about these themes and progress in our Corporate Values & Sustainability Report.
Read Our 2024 Report

Patent litigation announcement

Read an update on the favorable ruling from the patent litigation involving our flagship therapy.
See Our Press Release

Maximizing impact for patients

Learn how our integrated research, development and commercial model is driving medical progress.
Explore Our 2023 Annual Report

A doctor showing a patient their results

Advancing our pipeline

Learn about our first pivotal trial in squamous cell carcinoma of the head and neck.
Read Our News

Woman sitting in front of computer smiling at camera

An exceptional employee experience

Experience more purposeful work and fulfilling opportunities.
See Open Jobs

Accelerating our impact in oncology

Develop next-generation cancer medicines with us.
Let’s Collaborate

Building a culture of inclusion

Learn about our journey in creating a diverse, collaborative workforce.
Learn More

Supporting our community

We are champions for causes we believe in.
See Our Impact

Inspired by science

We are innovating at the forefront of cancer care. Our comprehensive approach is powered by a broad array of diverse biotherapeutics and small molecule programs for the treatment of cancer exploring multiple modalities and mechanisms of action.

Leveraging deep expertise in chemistry and biology, as well as strategic partnerships, we are advancing various biotherapeutics that have the potential to become anti-cancer therapies, such as bispecific antibodies, antibody-drug conjugates and other innovative treatments.

Our discovery teams are advancing multiple small molecule programs internally and through our industry collaborations.

Our R&D programs include next-generation approaches to established targets, as well as opportunities to be first-in-class by applying a range of modalities and mechanisms of action across biologics and small molecules.

Clinical Trials & Pipeline

Powered by innovation and hope

At Exelixis, cancer is our cause. Over the course of the past three decades, we’ve evolved into a multi-platform cancer company dedicated to creating treatment regimens that challenge the status quo and bring us closer to a potential cure – all to give more patients hope for the future.

Our Story

Advancing science for hope

Everyone at Exelixis plays a role in advancing our mission through our innovative drug discovery, development and commercialization efforts. We take pride in our shared purpose, knowing the magnitude of our impact expands with every medicine we create and every form of cancer tumor type we treat.

Inside Exelixis